Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD.
Tosato
G
G
Division of Hematologic Products, Food and Drug Administration, Bethesda, MD 20892, USA.
Teruya-Feldstein
J
J
Setsuda
J
J
Pike
S E
SE
Jones
K D
KD
Jaffe
E S
ES
D000818:Animals; D001402:B-Lymphocytes / Q000166:cytology* / Q000187:drug effects / Q000821:virology; D002460:Cell Line; D002472:Cell Transformation, Viral; D054357:Chemokine CXCL10; D054370:Chemokine CXCL9; D019743:Chemokines, CXC / Q000494:pharmacology / Q000502:physiology; D004854:Herpesvirus 4, Human / Q000378:metabolism; D006801:Humans; D007231:Infant, Newborn; D016753:Interleukin-10; D007378:Interleukins / Q000494:pharmacology / Q000502:physiology; D008213:Lymphocyte Activation; D008222:Lymphokines / Q000494:pharmacology / Q000502:physiology*; D008232:Lymphoproliferative Disorders / Q000276:immunology*; D008233:Lymphotoxin-alpha / Q000494:pharmacology / Q000502:physiology; D051379:Mice; D016377:Organ Transplantation / Q000009:adverse effects*; D016212:Transforming Growth Factor beta / Q000494:pharmacology / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology / Q000502:physiology; D014763:Viral Matrix Proteins / Q000378:metabolism; D014764:Viral Proteins / Q000494:pharmacology / Q000502:physiology
C066460:BCRF1 protein, Human herpesvirus 4; C111954:CXC chemokine Mig; D054357:Chemokine CXCL10; D054370:Chemokine CXCL9; D019743:Chemokines, CXC; C037662:EBV-associated membrane antigen, Epstein-Barr virus; D007378:Interleukins; D008222:Lymphokines; D008233:Lymphotoxin-alpha; D016212:Transforming Growth Factor beta; D014409:Tumor Necrosis Factor-alpha; D014763:Viral Matrix Proteins; D014764:Viral Proteins; D016753:Interleukin-10